Papers
7
Total Citations
137
H-Index
6
About
Laura Marandino is a leading urologic oncologist whose research centers on optimizing surgical outcomes for kidney and bladder cancers, with a particular focus on robotic partial nephrectomy (RPN). Her major contributions include systematic reviews that have shaped clinical practice, such as her 2023 work comparing resection techniques during RPN (56 citations) and her quantitative synthesis of off-clamp versus on-clamp approaches for the European Association of Urology Young Academic Urologists Renal Cancer Study Group (18 citations). She has also advanced the field through investigations of single-port robotic surgery and its impact on perioperative outcomes and hospital stay (22 citations). Beyond surgical technique, Marandino has explored frailty's influence on partial nephrectomy outcomes in a large retrospective study (17 citations) and challenged treatment paradigms for muscle-invasive bladder cancer with work on neoadjuvant chemotherapy and immunotherapy (13 citations). Her 2024 development of a preoperative risk calculator for nephron-sparing surgery completion demonstrates her commitment to personalized surgical planning. With over 130 citations across her most-cited works, Marandino is establishing herself as a key voice in evidence-based urologic oncology, bridging technical innovation with patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review56 citations · 2023
- 2
- 3
- 4
- 5
- 6
- 7